Just over two years <a href=" http://uscathleticsclub.asn.au/savitra-name/ ">savitra price </a> Panmure Gordon rated Man’s shares a Buy and said they are at the bottom of its valuation range “which should mean little downside but the undoubted upside available to investors may take time to materialise.” But it pointed out that there is “little visibility over future profits and the ability of [flagship fund] AHL to generate meaningful performance fees”. Man rose 4.5p to 88.1p.